| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |